Connect with us

Published

on

For years, Amazon warehouse staffers have complained about unsafe working conditions and the injury risks they face when rushing to fill packages and get them to customers in two days or less.

While Amazon claims its injury rate is coming down, facility-level data released last month from the U.S. Labor Department’s Occupational Safety and Health Administration underscores worker concerns, showing that in 2022 Amazon laborers were injured at a rate of 6.9 for every 100. In January, OSHA investigators cited Amazon for “failing to keep workers safe.”

Industrywide numbers for last year won’t be released until November, but OSHA head Doug Parker said Amazon has a history of injury rates that are far higher than others in the warehouse category. In 2021, Amazon’s injury rate was almost 1.5 times the industry average. At some Amazon warehouse locations, Parker said, the rate was as high as 12 workers out of 100.

“That’s more than 10% of the workforce every year who are receiving injuries on the job that are serious enough that they have to take time away from their jobs,” Parker said, regarding those warehouses. “We know that it’s affecting thousands of workers and it’s very alarming.”

Bobby Gosvener is one former worker living with pain.

Gosvener worked at an Amazon warehouse in Tulsa, Oklahoma, until 2020. He said after a conveyor belt malfunctioned that December he was left with a herniated disk that required neck surgery. He’s now on permanent partial disability.

“I have to live with this injury for the rest of my life,” Gosvener said. “I hate to this day even to order through Amazon because it’s so convenient, but every time I look at a box, I think of the process of what went through it and who got hurt in the midst of it.”

Jennifer Crane works through pain at an Amazon warehouse in St. Peters, Missouri, after hurting her wrist in October. She said she tore a ligament from “packing a case of sparkling water repetitively all day, along with dog food and Gatorades.” She wears a brace to help her get through the day.

“After like two hours of heavy lifting, I’m taking pain meds,” Crane said.

She needs the job. Crane became a single mom to her seven sons when her husband died of a heart attack in 2019.

“I’ve got to be able to support them. I have bills to pay,” she said. Crane said she knows she could look for other work, “but right now I’m in the fight to try to make it better there for everybody.”

Amazon worker Jennifer Crane at her house outside St. Louis, Missouri, in 2022.

Missouri Workers Center

Crane is circulating a petition at her warehouse asking for a slower pace of work, more breaks, ergonomic changes and equipment updates. 

In response to those accounts of injury and pain, Amazon spokesperson Maureen Lynch Vogel said in a statement, “Amazon worked diligently to accommodate both employees and ensure they had what they needed not only to work safely but also to recover. Any claim to the contrary is false.”

Amazon’s self-reported injury rate fell 9% between 2021 and 2022. Beyond warehouses, the e-commerce giant says its injury rate across all worldwide operations, some 1.5 million employees, dropped nearly 24% from 2019 to 2022.

“I don’t dispute that their injury rates may have gone down some over a period of time, but they’re still not good enough,” OSHA’s Parker said.

Strategic Organizing Center (SOC), a coalition of labor unions, crunched OSHA’s new data and found Amazon’s injury rate was more than double that of all non-Amazon warehouses in 2022. According to the report, Amazon employed 36% of U.S. warehouse workers in 2022, but was responsible for more than 53% of all serious injuries in the industry.

Kelly Nantel, an Amazon spokesperson, said by email that the group’s findings “paint an inaccurate picture.”

“The safety and health of our employees is, and always will be, our top priority, and any claim otherwise is inaccurate,” Nantel said. “We’re proud of the progress made by our team and we’ll continue working hard together to keep getting better every day.”

“Amazon’s apparent attitude about this is to deny that they have a problem,” said Eric Frumin, SOC’s health and safety director.

Federal scrutiny

Federal authorities are now looking into the health and safety issues, with inspections across seven Amazon warehouses in five states last summer. OSHA issued citations at all seven locations.

“At every single facility we found serious hazards that were putting workers at serious risk of bodily harm,” Parker said. “What is most concerning is the scale. We have every reason to believe that the types of processes where we found hazards in these facilities are processes that are used in Amazon facilities across the country.”

OSHA also acted on referrals from the U.S. Attorney’s Office for the Southern District of New York, which pointed to similar hazards in its own investigation of the facilities. Two more warehouses were cited for safety violations by Washington state’s Department of Labor. OSHA also cited Amazon for 14 record-keeping violations, finding that the company failed to properly report worker injuries and illnesses.

Amazon is appealing all the citations. If they’re upheld, the company will have to pay its first ever federal fines for worker musculoskeletal injuries. So far, they total nearly $152,000. The Washington state DOJ fines add an additional $81,000.

Amazon has a market cap of roughly $1 trillion and last year generated revenue of over $500 billion.

“There’s no amount of money that the Labor Department can impose as a penalty that’s going to make a difference to a company that runs through billions of dollars a day,” Frumin said. “What matters is, are they going to respect the need for their workers to be safe?”

In a rare case of federal cooperation, the Department of Justice is also investigating Amazon, asking if the company “engaged in a fraudulent scheme designed to hide the true number of injuries,” according to a January press release. The DOJ’s civil division is looking into whether Amazon executives made “false representations” to lenders about its safety record to obtain credit. 

In a statement, Amazon told CNBC, “We strongly disagree with the allegations and are confident that this process will ultimately show they’re unfounded.” The company said it’s expanding the team responsible for record-keeping.

‘If you’re rushing, you’re going to make mistakes’

For Daniel Olayiwola, who’s worked at Amazon since 2017, the primary concern is the pressure to work quickly.

“You have to make sure these rates are met,” Olayiwola said. “Otherwise you’re going to be getting a write-up. Then you’re not going to be getting any opportunities to switch positions or move up at all.”

Olayiwola introduced a proposal at last year’s annual shareholders meeting, asking Amazon to stop tracking workers’ rate of work and what’s called “time off task.” The measure failed. 

“It is a big contributor to the amount of injuries we get at Amazons worldwide,” Olayiwola said. “I can hands down say that. If you’re rushing, you’re going to make mistakes and someone’s going to get hurt.”

Amazon worker Daniel Olayiwola poses outside his warehouse in San Antonio, Texas, on March 9, 2023.

Lucas Mullikin

Olayiwola drives a forklift to pick up heavy items in a warehouse in San Antonio, Texas. He said the slowest acceptable rate at the facility is about 22 an hour, “meaning you’d have to pick an item every three minutes.”

“Which is crazy if the item is a mirror, a dresser, a bed frame,” Olayiwola said. “But you have to keep picking these items and you have to drop them off at these designated drop zones.”

An Amazon spokesperson said in an email that the “pace of work” isn’t referenced in any of OSHA’s citations. But the Southern DIstrict of New York’s investigations at six warehouses cited pace of work as an issue. And three states — New York, California, and Washington — have passed legislation seeking to curtail the use of productivity quotas at Amazon warehouses. 

In the meantime, Olayiwola has sought support from United for Respect, a retail worker advocacy group, and he hosts a podcast called “Surviving Scamazon.” Like Crane, he wants to support his family while working to produce change from the inside. His wife is pregnant with their second child, and he calls his work at Amazon a “necessary evil.”

OSHA says similar investigations are currently underway at 10 other Amazon sites, with broader investigations pending at dozens more.

Watch the video to learn more.

Continue Reading

Technology

Anne Wojcicki has a new offer to take 23andMe private, this time for $74.7 million

Published

on

By

Anne Wojcicki has a new offer to take 23andMe private, this time for .7 million

Anne Wojcicki attends the WSJ Magazine Style & Tech Dinner in Atherton, California, on March 15, 2023.

Kelly Sullivan | Getty Images Entertainment | Getty Images

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and Exchange Commission.

Wojcicki and New Mountain have offered to acquire all of 23andMe’s outstanding shares in cash for $2.53 per share, or an equity value of approximately $74.7 million. The company’s stock closed at $2.42 on Friday with a market cap of about $65 million.

The offer comes after a turbulent year for 23andMe, with the stock losing more than 80% of its value in 2024. In January, the company announced plans to explore strategic alternatives, which could include a sale of the company or its assets, a restructuring or a business combination. 

Read more CNBC tech news

23andMe has a special committee of independent directors in place to evaluate potential paths forward. The company appointed three new independent directors to its board in October after all seven of its previous directors abruptly resigned the prior month. The special committee has to approve Wojcicki and New Mountain’s proposal.

“We believe that our Proposal provides compelling value and immediate liquidity to the Company’s public stockholders,” Wojcicki and Matthew Holt, managing director and president of private equity at New Mountain, wrote in a letter to the special committee on Thursday.

Wojcicki previously submitted a proposal to take the company private for 40 cents per share in July, but it was rejected by the special committee, in part because the members said it lacked committed financing and did not provide a premium to the closing price at the time.

Wojcicki and New Mountain are willing to provide secured debt financing to fund 23andMe’s operations through the transaction’s closing, the filing said. New Mountain is based in New York and has $55 billion of assets under management, according to its website.

23andMe declined to comment.

WATCH: The rise and fall of 23andMe

The rise and fall of 23andMe

Continue Reading

Technology

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Published

on

By

Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage

Hims & Hers

Shares of Hims & Hers Health tumbled more than 23% on Friday after the U.S. Food and Drug Administration announced that the shortage of semaglutide injection products has been resolved.

Semaglutide is the active ingredient in Novo Nordisk‘s blockbuster weight loss drug Wegovy and diabetes treatment Ozempic. Those medications are part of a class of drugs called GLP-1s, and demand for the treatments has exploded in recent years. As a result, digital health companies such as Hims & Hers have been prescribing compounded semaglutide as an alternative for patients who are navigating volatile supply hurdles and insurance obstacles.

Compounded drugs are custom-made alternatives to brand-name drugs designed to meet a specific patient’s needs, and compounders are allowed to produce them when brand-name treatments are in shortage. The FDA doesn’t review the safety and efficacy of compounded products.

Hims & Hers began offering compounded semaglutide to patients in May, and it owns compounding pharmacies that produce the medications.

Compounded medications are typically much cheaper than their branded counterparts. Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance.

Read more CNBC tech news

The FDA said Friday that it will start taking action against compounders for violations in the next 60 to 90 days, depending on the type of facility, in order to “avoid unnecessary disruption to patient treatment.”

“Now that the FDA has determined the drug shortage for semaglutide has been resolved, we will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO Andrew Dudum posted Friday on X. “We’re also closely monitoring potential future shortages, as Novo Nordisk stated two weeks ago that it would continue to have ‘capacity limitations’ and ‘expected continued periodic supply constraints and related drug shortage notifications.'”

Him & Hers’ weight loss offerings have been a massive hit with investors. Shares of the company climbed more than 200% last year, and the stock is already up more than 100% this year despite Friday’s move.

Even before it added compounded GLP-1s to its portfolio, the company said in its 2023 fourth-quarter earnings call that it expects its weight loss program to bring in more than $100 million in revenue by the end of 2025.

Despite the turbulent regulatory landscape, Hims & Hers has showed no signs of slowing down.

On Friday, the company announced it has acquired a U.S.-based peptide facility that will “further verticalize the company’s long-term ability to deliver personalized medications.” Hims & Hers will explore advances across metabolic optimization, recovery science, biological resistances, cognitive performance and preventative health through the acquisition, the company said.

That move comes just days after Hims & Hers also bought Trybe Labs, the New Jersey-based at-home lab testing facility. Trybe Labs will allow Hims & Hers to perform at-home blood draws and more comprehensive pretreatment testing.

Hims & Hers did not disclose the terms of either deal.

WATCH: Hims & Hers Super Bowl ad sparks controversy

Hims & Hers Super Bowl ad sparks controversy

Continue Reading

Technology

Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems

Published

on

By

Tesla recalls more than 375,000 vehicles in U.S. due to failing power-assisted steering systems

Tesla models Y and 3 are displayed at a Tesla dealership in Corte Madera, California, on Dec. 20, 2024.

Justin Sullivan | Getty Images

Tesla is voluntarily recalling 376,241vehicles in the U.S. to correct an issue with failing power-assisted steering systems, according to records posted to the website of the U.S. National Highway Traffic Safety Administration.

In a safety recall report posted on the NHTSA website, Tesla said the recall includes Model 3 and Model Y vehicles that were manufactured for sale in the U.S. from Feb. 28, 2023, to October 11, 2023, and that were equipped with a certain older software release.

The records said printed circuit boards in the steering systems in affected vehicles could become overstressed, causing the power-assist steering to fail in some cases when a Tesla vehicle rolled to a stop and then accelerated.

When electronic power-assist steering systems fail in a Tesla, drivers need to exert more force to steer their cars, which can increase the risk of a collision.

Read more CNBC tech news

Tesla told the vehicle safety regulator that it was not aware of any crashes, injuries or deaths related to the power steering failures, and that it was offering an over-the-air software update as a remedy.

The recall follows an earlier related probe and voluntary recall in China concerning the same systems.

President Donald Trump has appointed Tesla CEO Elon Musk to lead a team that is slashing the federal government workforce, and in some cases, regulations and entire agencies. Those cuts already affected the NHTSA, an agency Musk has long seen as standing in the way of some of his ambitions at Tesla.

The regulator has been engaged in a yearslong investigation into safety defects in the systems that Tesla markets currently as its Autopilot and Full Self-Driving (Supervised) options. The features do not make Tesla cars into robotaxis. They require a human driver ready to steer or brake at any time.

The Washington Post reported on Thursday that Musk’s team has led mass firings at the NHTSA, reducing the agency’s workforce and capacity to investigate companies including Tesla by about 10%.

Tesla didn’t respond to a request for comment.

WATCH: Tesla stock hinges on new vehicles being introduced

Tesla stock hinges on new vehicles being introduced, says Canaccord's  George Gianarikas

Continue Reading

Trending